Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Fentanyl vs Oral Morphine for Breakthrough Pain in Gynecologic Cancer
NCT05037539Phase 2Completed
- Sponsor
- Ministry of Public Health
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in breakthrough pain, sponsored by Ministry of Public Health. Started Jun 2021; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT05037539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05037539.